Skip to main content
. 2019 Mar 1;14:585–595. doi: 10.2147/COPD.S195438

Figure 3.

Figure 3

Repeatability of peak inspiratory flow rate (PIFR) from baseline to 2–4 weeks, measured against R2 low–medium resistance inhaler (eg, Diskus® and Ellipta®; blue dashed line) and R5 high resistance inhaler (Handihaler®; orange solid line).